A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT

NCT04897880 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Drug supply

Conditions

Rhabdoid Tumor
Atypical Teratoid/Rhabdoid Tumor
Malignant Rhabdoid Tumor
Recurrent Brain Tumor, Childhood

Interventions

DRUG: Panobinostat

Sponsor

Australian & New Zealand Children's Haematology/Oncology Group

Collaborators

[object Object]
[object Object]